Clinical trial
Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer
NCT00283075 · The Rogosin Institute, Other · Completed
Key facts
| NCT number | NCT00283075 |
|---|---|
| Title | Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer |
| Official title | Use of Mouse Renal Adenocarcinoma Cell-containing Agarose-agarose Macrobeads in the Treatment of Patients With End-stage, Treatment-resistant Epithelial-derived Cancer |
| Lead sponsor | The Rogosin Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Intraabdominal Cancers (Various Types) |
| Intervention type | Biological |
| Interventions | Cancer Macrobead placement in abdominal cavity |
| Enrollment | 56 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Feb 1, 2015 |
| First posted | Jan 27, 2006 |
| Last update posted | Jan 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: